Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-14T03:21:30.406Z Has data issue: false hasContentIssue false

Effects of an anti-exospore monoclonal antibody on microsporidial development in vitro

Published online by Cambridge University Press:  01 December 1998

F. J. ENRIQUEZ
Affiliation:
Department of Veterinary Science and Microbiology, University of Arizona, Tucson, AZ 85721, USA
G. WAGNER
Affiliation:
Department of Veterinary Science and Microbiology, University of Arizona, Tucson, AZ 85721, USA
M. FRAGOSO
Affiliation:
Department of Veterinary Science and Microbiology, University of Arizona, Tucson, AZ 85721, USA
O. DITRICH
Affiliation:
Institute of Parasitology AS CR, Ceske Budejovice, Czech Republic

Abstract

In this study we evaluated the effects of the anti-microsporidial exospore monoclonal antibody 3B6, recognizing 3 Encephalitozoon species, Encephalitozoon intestinalis (Syn. Septata intestinalis), Encephalitozoon cuniculi, and Encephalitozoon hellem on microsporidial growth in vitro. Pre-treatment of spores for 24 h with mAb 3B6 resulted in 21–29% fewer infected host cells 4 days after inoculation of the cultures compared to cultures pre-treated with medium or an irrelevant isotype control mAb (P<0·001). Fewer intracellular spores (1·2±0·2) in infected cells were found when mAb 3B6 was present in cultures compared to cultures with medium alone (4·3±0·8) or an irrelevant isotype control mAb (4·2±0·9; P<0·001). This decrease appeared not to be dependent on time of exposure, mAb concentration, or presence of complement. It is concluded that antibodies, particularly those directed to potential neutralizing-sensitive epitopes on spores, may have a role in the control of microsporidial growth in vitro.

Type
Research Article
Copyright
1998 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)